Research Protocol

KLOW Blend 80mg— Research Protocol

Dosage Calculator → How to Reconstitute →

Quickstart Highlights

KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair[1][2]. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing[3][4]. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling[5][6]. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration[7][8].

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[9].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 14–28 days and avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

How It Works

KLOW combines four peptides with complementary mechanisms of action:

  • TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure[1]. Preclinical studies demonstrate accelerated wound healing, reduced inflammation, and tissue regeneration[2].
  • BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle healing through enhanced angiogenesis and growth factor modulation[3]. Animal studies show favorable tissue repair outcomes[4].
  • KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects[5][6].
  • GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound healing, and modulates gene expression related to tissue remodeling[7][8].

Potential Benefits & Side Effects

Observations from preclinical and early-stage research.

Potential Benefits

  • Accelerated tissue repair and wound healing through multiple complementary pathways[1][3].
  • Reduced inflammation via NF-κB inhibition and cytokine modulation[5][7].
  • Enhanced collagen synthesis and connective tissue support[8].
  • Promotion of angiogenesis and improved blood flow to healing tissues[2].
  • Potential support for musculoskeletal recovery and joint health[3].

Possible Side Effects

  • Mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.
  • Occasional lightheadedness reported with some peptides due to vasodilatory effects.
  • Limited human clinical data; most safety observations derive from preclinical studies[4].

References

For laboratory and research use only. Minimum 98% purity. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. This protocol is provided for educational and research purposes only and is not medical advice. The purchaser accepts full responsibility for safe handling, storage and lawful use.